Mitigation Strategy Program News Today

James attended a rally in support of defending access to mifepristone, which is used as part of a two-drug regimen for some abortions.

Curricula should require comprehensive training for providing contraceptive care, helping students perform duties confidently and competently.

HIGH COUNTRY — Boone Drug will not participate in the voluntary Mifepristone Risk Evaluation and Mitigation Strategy Program due to the organization’s belief that it has a responsibility to protect

The Food and Drug Administration (the “FDA”) has approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy (“REMS”) Program, increasing the accessibility of...

The FDA approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy, REMS, Program. The FDA’s approval of commercial dispensing of mifepristone likely will not change the current practice of prescribing and dispensing mifepristone for abortion.

CVS Health and Walgreens, the two largest retail pharmacy store chains in the U.S., have announced that they will sell abortion pills over the counter. This followed a rule change by the Food and [...]